Announced Fri, 17 Apr · 16:11 IST
Vivimed Labs admitted to insolvency resolution by NCLT
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.5%1-day move
₹7.75
prior close
₹7.81
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.5+2.4+0.0-0.8-6.5-11.1-11.6-13.2-11.1-9.0-17.0-15.5-23.9-31.6
Up moveDown movePending
AI summary
NCLT Bengaluru admitted Vivimed Labs to Corporate Insolvency Resolution Process (CIRP) on April 15, 2026, following a petition by Blue Cube Germany Assets GmbH, an operational creditor, for unpaid debt of ₹32.79 crore (including interest) from chemical supplies made in 2012-2014. A moratorium is in effect, the board of directors is suspended, and an Interim Resolution Professional has been appointed. Next hearing: June 24, 2026.
Likely market impact
Major negative: stock likely to hit lower circuit, equity may be diluted/written off in resolution, and lenders gain control of the company.